The Phase III trial will be conducted at Dr Ram Manohar Lohia Institute of Medical Sciences (RMLIMS), Era’s Lucknow Medical College & Hospital, and King George’s Medical University (KGMU).
CSIR-CDRI has not only developed the economical process technology for the drug in record time but also licensed the technology for manufacturing and marketing the drug to Medizest Pharmaceuticals of Goa. How concerned are you about the spread of Coronavirus?View ResultsMedizest has already secured a test license from the Drug Controller General of India (DCGI).
CSIR-CDRI director Tapas Kundu said that all the raw materials required for Umifenovir are available in the country and if the trial comes out a success, Umifenovir will prove to be a safe,.